LPL Receptor
All Product Categories
-
LPL Receptor Inhibitors
(50)
View all products
-
LPL Receptor Agonists
(64)
View all products
-
LPL Receptor Antagonists
(52)
View all products
-
LPL Receptor Activators
(11)
View all products
-
LPL Receptor Modulators
(11)
View all products
-
LPL Receptor Control
(1)
View all products
-
LPL Receptor Ligand
(1)
View all products
-
LPL Receptor Related Products (204)
Related Products (204)
-
Zectivimod
0 ImagesZectivimod is a sphingosine-1-phosphate receptor agonist. Zectivimod can be used for the research of autoimmune diseases，chronic inflammatory diseases and immunoregulation disorders.
-
Sumonerimod hemicalcium
0 ImagesCat. No.: HY-156565ACAS No.: 2941310-03-6Synonyms: S1P1 agonist 6 hemicalciumS1P1 agonist 6 hemicalcium (Compound I) is a S1P1 agonist that reduces autoimmune ability by blocking the transportation of lymphocytes. S1P1 agonist 6 hemicalcium can be used as an immunosuppressive agent in the study of various autoimmune diseases research.
-
Myristoyl pentapeptide-17
0 ImagesCat. No.: HY-P0103CAS No.: 959610-30-1Myristoyl pentapeptide-17 can stimulate eyelash growth by stimulating keratin production. Myristoyl pentapeptide-17 promotes the delivery of key ingredients in the serum, such as the growth factors and lysophosphatidic acid.
-
BMS-960
0 ImagesCat. No.: HY-120611ACAS No.: 1265323-40-7BMS-960 is a potent and selective S1P1 receptor agonist containing isoxazole, which can be used in the research of immune diseases and vascular diseases.
-
CYM50358 hydrochloride
0 ImagesCat. No.: HY-110314CAS No.: 1781750-72-8CYM50358 hydrochloride (compound 4v) is a potent, selective sphingosine-1-phosphate 4 (S1P4) receptor antagonist. CYM50358 hydrochloride can be used in the study of influenza infection.
-
S1PR1 agonist 1
0 ImagesCat. No.: HY-143864CAS No.: 2700209-37-4S1PR1 agonist 1 is a potent agonist of S1PR1. Sphingosine-1-phosphate (S1P) is a cell membrane-derived lysophospholipid signalling molecule that exerts its physiological functions mainly by stimulating some members of the G protein-coupled receptor family. S1PR1 agonist 1 has the potential for the research of autoimmune diseases (extracted from patent WO2021175223A1, compound 22).
-
LPA1 receptor antagonist-7
0 ImagesCat. No.: HY-182787CAS No.: 3057457-78-7LPA1 receptor antagonist-7 is a LPA1 antagonist. LPA1 receptor antagonist-7 blocks downstream signaling pathways mediated by LPA1. LPA1 receptor antagonist-7 inhibits LPA-induced migration and invasion of cancer cells. LPA1 receptor antagonist-7 can be used for the research of triple-negative breast cancer.
-
S1PR1 agonist 2
0 ImagesCat. No.: HY-143865CAS No.: 2695535-01-2S1PR1 agonist 2 is a potent agonist of S1PR1. Sphingosine-1-phosphate (S1P) is a cell membrane-derived lysophospholipid signalling molecule that exerts its physiological functions mainly by stimulating some members of the G protein-coupled receptor family. S1PR1 agonist 2 has the potential for the research of autoimmune diseases (extracted from patent WO2021175225A1, compound 1).
-
S1P5 receptor antagonist 1
0 ImagesCat. No.: HY-164584CAS No.: 1621065-22-2S1P5 receptor antagonist 1 is a selective, blood-brain barrier-permeable S1P5 receptor antagonist with an EC50 of 0.1 nM and a Ki of 4.4 nM. S1P5 receptor antagonist 1 inhibits the migration of natural killer cells towards sphingosine 1-phosphate in vitro, with no effect on T cell migration. S1P5 receptor antagonist 1 can be used in the research of central nervous system diseases.
-
Fingolimod phosphate-d4
0 ImagesCat. No.: HY-15381SCAS No.: 1794828-93-5Synonyms: FTY720 phosphate-d4Fingolimod phosphate-d4 is deuterium labeled FTY720 Phosphate.
-
Glycocholic acid sodium (Standard)
0 ImagesCat. No.: HY-N1423ARCAS No.: 863-57-0Glycocholic acid (sodium) (Standard) is the analytical standard of Glycocholic acid sodium (HY-N1423A). This product is intended for research and analytical applications. Glycocholic acid sodium is a bile acid derivative. Glycocholic acid downregulates MDR1, Bcl-2, MRP1, MRP2 and FXR, upregulates Bax, p53, caspase-9, caspase-3, TGR5 and S1PR2. Glycocholic acid sodium inhibits multidrug resistance and efflux pumps, induces mitochondrial apoptosis, and enhances chemosensitivity. Glycocholic acid sodium modulates related bile acid receptor signaling. Glycocholic acid sodium suppresses growth and conjugation of Enterobacteriaceae and increases their antibiotic susceptibility. Glycocholic acid sodium can be used for the research of colon adenocarcinoma and cholangiocarcinoma (CCA).
-
LPAR1 antagonist 2
0 ImagesCat. No.: HY-160661CAS No.: 1664336-46-2LPAR1 antagonist 2 (example 76) is an LPAR1 antagonist with an average IC50 of 130 nM.
-
Obicetrapib sodium
0 ImagesCat. No.: HY-18778ACAS No.: 866399-88-4Synonyms: TA-8995 sodium; DEZ-001 sodium; AMG-899 sodiumObicetrapib (TA-8995; DEZ-001) sodium is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib sodium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib sodium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD).
-
(Rac)-1-Oleoyl lysophosphatidic acid
0 ImagesCat. No.: HY-137862ACAS No.: 22002-87-5Synonyms: (Rac)-1-Oleoyl-sn-glycero-3-phosphate; (Rac)-1-Oleoyl-LPA(Rac)-1-Oleoyl lysophosphatidic acid is an isomer of 1-Oleoyl lysophosphatidic acid sodium (HY-107614). 1-Oleoyl lysophosphatidic acid sodium is a bioactive lipid that can activate the LPA receptors .
-
XL541
0 ImagesCat. No.: HY-18165CAS No.: 1221878-06-3XL541 is a potent, selective S1P1 antagonist. XL541 inhibits GDP-GTP exchange. XL541 causes frank surface hemorrhaging of tumors. XL541 collaborates with Paclitaxel (HY-B0015) to exhibit antitumor activity against breast cancer and lung cancer.
